Stay updated on Cabotegravir vs TDF/FTC in Women Clinical Trial
Sign up to get notified when there's something new on the Cabotegravir vs TDF/FTC in Women Clinical Trial page.

Latest updates to the Cabotegravir vs TDF/FTC in Women Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded a consolidated Locations section listing study sites (South-East District, Nyanza, Central Region, Gauteng, KwaZulu-Natal, Western Cape, Mashonaland East Province) and updated the revision tag to v3.3.3; removed the previous 'X Locations' subheadings (e.g., 'South-East District Locations', 'Nyanza Locations').SummaryDifference0.7%

- Check55 days agoChange DetectedPublication notes updated to indicate PubMed-sourced publications are automatically filled and the page revision was updated to v3.3.2; the older version note referencing v3.2.0 was removed.SummaryDifference0.1%

- Check62 days agoChange DetectedThe government funding notice banner at the top of the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check76 days agoChange DetectedNo core content changes detected (no pricing, stock, or time-slot updates); the Study Details page remains unchanged in purpose and content, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check97 days agoChange DetectedPage content updated with new future dates and a new Mbabane, Eswatini reference; older Eswatini location mentions and prior Last Update line removed.SummaryDifference0.7%

Stay in the know with updates to Cabotegravir vs TDF/FTC in Women Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabotegravir vs TDF/FTC in Women Clinical Trial page.